Adynxx, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 6
- Market Cap
- -
- Website
- http://www.adynxx.com
Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Mastectomy in Patients With High PCS Scores
Phase 2
Withdrawn
- Conditions
- Pain, Postoperative
- Interventions
- Drug: Placebo 6 mL
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- Adynxx, Inc.
- Registration Number
- NCT04104919
Study to Evaluate a Preop Dose of Brivoligide Injection for Pain After Knee Replacement in Patients With High PCS Scores
Phase 2
Withdrawn
- Conditions
- Pain, Postoperative
- Interventions
- Drug: Placebo 6 mL
- First Posted Date
- 2019-01-09
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- Adynxx, Inc.
- Registration Number
- NCT03797612
- Locations
- 🇺🇸
Research Site, Phoenix, Arizona, United States
Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery
Phase 2
Completed
- Conditions
- Post-surgical Pain
- Interventions
- Drug: AYX1 Injection 660 mg/6 mLDrug: Placebo Injection 6 mL
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- Adynxx, Inc.
- Target Recruit Count
- 210
- Registration Number
- NCT02807428
- Locations
- 🇺🇸
Mississippi Sports Medicine, Jackson, Mississippi, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Alabama Orthopedic Center, Birmingham, Alabama, United States
Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery
Phase 2
Completed
- Conditions
- Postsurgical Pain
- Interventions
- Drug: AYX1 Injection 660 mg / 6 mLDrug: Placebo Injection 6 mLDrug: AYX1 Injection 1100 mg / 10 mLDrug: Placebo Injection 10 mL
- First Posted Date
- 2014-03-07
- Last Posted Date
- 2015-08-04
- Lead Sponsor
- Adynxx, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT02081703
Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery
Phase 2
Completed
- Conditions
- Postsurgical Pain
- Interventions
- Drug: AYX1 Injection 330 mgDrug: Placebo InjectionDrug: AYX1 Injection 110 mg
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2015-01-27
- Lead Sponsor
- Adynxx, Inc.
- Target Recruit Count
- 102
- Registration Number
- NCT01731730
© Copyright 2025. All Rights Reserved by MedPath